Offerings - Offering: 1 |
Aug. 06, 2025
USD ($)
shares
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Common Stock, par value of $1.00 per share, issuable pursuant to the Registrant's 2001 Employee Stock Purchase Plan for United States Employees |
| Amount Registered | shares | 4,200,000 |
| Proposed Maximum Offering Price per Unit | 81.17 |
| Maximum Aggregate Offering Price | $ 340,914,000.00 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 52,193.93 |
| Offering Note | (1) This Registration Statement covers, in addition to the number of shares of Edwards Lifesciences Corporation, a Delaware corporation (the "Company" or the "Registrant"), common stock, par value $1.00 per share (the "Common Stock"), stated above, options and other rights to purchase or acquire the shares of Common Stock covered by this Registration Statement and, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), an additional indeterminate number of shares, options and rights that may be offered or issued pursuant to the 2001 Employee Stock Purchase Plan for United States Employees, as amended and restated (the "Plan"), as a result of one or more adjustments under the Plan to prevent dilution resulting from one or more stock splits, stock dividends or similar transactions. (2) Estimated solely for the purpose of calculating the amount of the registration fee. The offering price per share and the aggregate offering price are based upon the average of the high and low prices of the Registrant's common stock as reported on the New York Stock Exchange on July 30, 2025, in accordance with Rule 457(c) of the Securities Act. (3) The registration fee has been calculated in accordance with Rule 457(h) and Rule 457(c) promulgated under the Securities Act. |